News
The latest news from Redoxis.
Partnering meetings
Malin Hultqvist (CSO) and Peter Olofsson (CEO) were during October representing Redoxis at BioPartnering in London and BIOEurope in Dusseldorf. Redoxis had promising meetings with more that 40 other companies and technology transfer representatives as well as discussion with large pharma companies. Redoxis will follow up these contacts with an ambition to built long lasting new relationships cross Europe and with US based companies.
read moreRedoxis is presented at “Tools of Science” and “Gothia Forum” websites
Redoxis is now represented as a CRO at the web sites “Tools of Science” ( http://www.toolsofscience.se) and “Gothia Forum” (https://gothiaforum.vgregion.se) which represents two gateways for connecting inustrial and academic partners involved in drug development, preclinical and clinical research.
read moreUpcoming meetings
Redoxis will be present at the Biopartnering meeting in London (10-11 Oct) and at the BioEurope meeting in Düsseldorf (31 Oct – 2 Nov). We will present our CRO services as well as own research projects.
read moreRedoxis focus experimental work in Lund
As a step in creating a good platform for CRO services, Redoxis is focusing all our experimental work to the unit in Lund. The Lund unit will from now perform both in vitro, ex vivo and in vivo experiments.
read moreGood luck Pia!
In the end of September, one of our in vitro specialists Pia worked her last day for Redoxis. Pia is heading for new adventures in the US and we wish her all the luck. In connection with this, we are now focusing all our experimental work to the Lund department. From first of October both in vitro, ex vivo and in vivo experiments will be performed at the Lund unit, recently re-enforced with a new in vivo specialist. We wish Pia all the best and good luck with her future...
read moreRedoxis recruits new in vivo researcher
As a step in the focus on CRO services for autoimmune inflammatory diseases, we have recruited a new researcher to reinforce our in vivo team. This recruitment makes it possible for us to take on more projects with a shorter time span from signed agreement to initiation of the study.
read more